CN Stock MarketDetailed Quotes

600572 Zhejiang Conba Pharmaceutical

Watchlist
  • 5.13
  • -0.05-0.97%
Market Closed May 10 15:00 CST
13.18BMarket Cap25.15P/E (TTM)

Zhejiang Conba Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Conba Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

1.82B

-14.38%
EPS(YoY)

0.08

-23.64%
Analyst Rating

Strong Buy

May 12, 2024

Zhejiang Conba Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.829B--
--2024/Q2-- / 1.794B--
--2024/Q11.824B / 2.210B--
--2023/Q41.549B / 1.596B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.829B--
--2024/Q2-- / 1.794B--
--2024/Q11.824B / 2.210B--
--2023/Q41.549B / 1.596B--

Zhejiang Conba Pharmaceutical Earnings Reports

  • Conn Bay 2024 First Quarter Report

    Apr 27 00:00

  • Conn Bay 2023 Annual Report Summary

    Apr 20 00:00

  • Full text of Conn Bay's 2023 Annual Report

    Apr 20 00:00

  • Announcement of the company\'s 2023 performance advance increase

    Jan 27 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: May 12, 2024

    Strong Buy

    • Strong Buy

      66.67%

    • Buy

      33.33%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg